News and Trends 21 May 2025
Layoffs in the US: what is going on with genomics companies?
Genomics companies have been slashing jobs and culling programs in the US. Learn about the layoffs that have struck the industry in 2025.
Gene therapy
- Latest Posts
In Depth 21 May 2025
Gene therapy for skin diseases: A field still finding its footing
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of something more?
Cracking the code: Delivering biotherapeutics successfully across EMEA
Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation.
News and Trends 12 May 2025
Pharma giants pull back on AAV research: what’s next for the gene therapy space?
Biopharmas have been scaling back on AAV research for sometime now. Find out why and what’s on the horizon for drug delivery methods.
Best in Biotech 29 Apr 2025
Six biotech companies leading the charge in hemophilia treatment
Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi therapies.
In Depth 9 Apr 2025
Cystic fibrosis: is the next blockbuster a gene therapy?
Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.
ADVERTISEMENT
ADVERTISEMENT
In Depth 7 Apr 2025
Will tRNA therapy be the next big thing in genetic disease treatment?
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
In Depth 2 Apr 2025
Beyond amyloid: The search for the next big thing in Alzheimer’s treatment
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.
In Depth 24 Jan 2025
Why are there only 20 cell and gene therapies in Europe?
There are 20 cell and gene therapies on Europe’s market versus 43 in the U.S. Find out more about this ecosystem.
Best in Biotech 16 Jan 2025
Ten first-in-class drugs on track for FDA approval in 2025
As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval in 2025.
In Depth 13 Jan 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.
News and Trends 10 Jan 2025
The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy
A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.
ADVERTISEMENT
